Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study.
Linsitinib (OSI-906) 用于治疗成人和儿童野生型胃肠道间质瘤，一项 SARC II 期研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-1069
von Mehren Margaret, George Suzanne, Heinrich Michael C, Schuetze Scott M, Yap Jeffrey T, Yu Jain Q, Abbott Amanda, Litwin Samuel, Crowley John, Belinsky Martin, Janeway Katherine A, Hornick Jason L, Flieder Douglas B, Chugh Rashmi, Rink Lori, Van den Abbeele Annick D
